• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿颅咽管瘤——多模式治疗的理论依据:埃及的经验

Pediatric craniopharyngioma--rationale for multimodal management: the Egyptian experience.

作者信息

Hafez Mohamed A, ElMekkawy Sherif, AbdelBadie Hazem, Mohy Mohamed, Omar Mohamed

机构信息

Department of Neurosurgery, Cairo University Hospitals, Cairo, Egypt.

出版信息

J Pediatr Endocrinol Metab. 2006 Apr;19 Suppl 1:371-80.

PMID:16700313
Abstract

BACKGROUND

Situated in a suprasellar location, craniopharyngiomas produce devastating endocrinological manifestations, visual impairment, and raised intracranial pressure, presenting a formidable disease entity for the neurosurgeon as well as the 'craniopharyngioma team'.

OBJECTIVE

To evaluate direct postoperative and long-term results based on the extent of surgical removal and administration of radiotherapy.

PATIENTS AND METHODS

Sixty-two new cases of pediatric craniopharyngioma were divided into three groups according to extent of removal: A (complete), B (subtotal), and C (partial). Groups A and B receiving primary postoperative radiotherapy were tagged groups Ar and Br.

RESULTS

Group A had significantly less recurrence rate than group B (p < 0.005); however, direct postoperative morbidity and mortality were worse (p < 0.05). Group C fared worse than the other two groups. In groups A and B with recurrence and in groups Ar and Br, radiotherapy provided long-term control.

CONCLUSION

The aim at first surgery should be total removal. Subtotal removal is warranted for more resilient tumors, while partial removal should be avoided as it provides poor results. Adjuvant radiotherapy is a useful tool in providing long-term tumor control.

摘要

背景

颅咽管瘤位于鞍上部位,可产生严重的内分泌表现、视力损害及颅内压升高,对神经外科医生及“颅咽管瘤治疗团队”而言是一种棘手的疾病。

目的

基于手术切除范围及放疗应用评估术后直接疗效及长期疗效。

患者与方法

62例儿童颅咽管瘤新病例根据切除范围分为三组:A组(全切)、B组(次全切除)和C组(部分切除)。接受术后初始放疗的A组和B组分别标记为Ar组和Br组。

结果

A组复发率显著低于B组(p < 0.005);然而,术后直接并发症发生率和死亡率更高(p < 0.05)。C组情况比其他两组更差。在复发的A组和B组以及Ar组和Br组中,放疗可实现长期控制。

结论

首次手术的目标应为全切。对于更具韧性的肿瘤,次全切除是必要的,而应避免部分切除,因为其效果不佳。辅助放疗是实现长期肿瘤控制的有效手段。

相似文献

1
Pediatric craniopharyngioma--rationale for multimodal management: the Egyptian experience.小儿颅咽管瘤——多模式治疗的理论依据:埃及的经验
J Pediatr Endocrinol Metab. 2006 Apr;19 Suppl 1:371-80.
2
Surgical management of craniopharyngiomas--experience with a pediatric series.颅咽管瘤的手术治疗——儿科系列病例经验
J Pediatr Endocrinol Metab. 2006 Apr;19 Suppl 1:355-66.
3
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.儿童和成人颅咽管瘤:121例长期随访的系统分析
Clin Endocrinol (Oxf). 2005 Apr;62(4):397-409. doi: 10.1111/j.1365-2265.2005.02231.x.
4
Craniopharyngioma. Analysis of factors that affect the outcome.
Saudi Med J. 2002 Jan;23(1):34-8.
5
Treatment of recurrent craniopharyngiomas.复发性颅咽管瘤的治疗
Kobe J Med Sci. 2003;49(5-6):123-32.
6
[Treatment of craniopharyngiomas in children. Retrospective analysis of 50 cases].[儿童颅咽管瘤的治疗。50例回顾性分析]
Arch Fr Pediatr. 1988 Mar;45(3):163-7.
7
Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse.颅咽管瘤患儿接受初次手术治疗,放疗推迟至复发后的临床结局。
Med Pediatr Oncol. 2003 Apr;40(4):214-8. doi: 10.1002/mpo.10247.
8
An analysis of related factors of surgical results for patients with craniopharyngiomas.颅咽管瘤患者手术结果的相关因素分析
Clin Neurol Neurosurg. 2012 Feb;114(2):149-55. doi: 10.1016/j.clineuro.2011.10.004. Epub 2011 Nov 5.
9
[Radical or conservative surgery in craniopharyngioma? Importance of individualized treatment!].[颅咽管瘤的根治性手术还是保守性手术?个体化治疗的重要性!]
Lakartidningen. 1995 May 31;92(22):2301-5.
10
Craniopharyngioma: surgical experience of 309 cases in China.颅咽管瘤:中国309例手术经验
Clin Neurol Neurosurg. 2008 Feb;110(2):151-9. doi: 10.1016/j.clineuro.2007.10.013. Epub 2007 Dec 3.

引用本文的文献

1
Differences in Treatment Outcomes Depending on the Adjuvant Treatment Modality in Craniopharyngioma.颅咽管瘤辅助治疗方式不同导致的治疗结果差异
Yonsei Med J. 2025 Mar;66(3):141-150. doi: 10.3349/ymj.2023.0566.
2
Adamantinomatous craniopharyngioma: evolution in the management.骨 牙 型 颅咽管瘤:治疗方式的演变。
Childs Nerv Syst. 2023 Oct;39(10):2613-2632. doi: 10.1007/s00381-023-06143-4. Epub 2023 Sep 20.
3
Global pediatric craniopharyngioma management modalities and outcomes.全球儿童颅咽管瘤的治疗方式与治疗结果
Childs Nerv Syst. 2024 Jan;40(1):47-56. doi: 10.1007/s00381-023-06088-8. Epub 2023 Jul 19.
4
Hypothalamic syndrome.下丘脑综合征。
Nat Rev Dis Primers. 2022 Apr 21;8(1):24. doi: 10.1038/s41572-022-00351-z.
5
Craniopharyngioma.颅咽管瘤。
Nat Rev Dis Primers. 2019 Nov 7;5(1):75. doi: 10.1038/s41572-019-0125-9.
6
Review of management and morbidity of pediatric craniopharyngioma patients in a low-middle-income country: a 12-year experience.低收入和中等收入国家小儿颅咽管瘤患者的管理与发病率回顾:12年经验
Childs Nerv Syst. 2017 Jun;33(6):941-950. doi: 10.1007/s00381-017-3411-4. Epub 2017 Apr 28.
7
The expanding role of the endonasal endoscopic approach in pituitary and skull base surgery: A 2014 perspective.经鼻内镜入路在垂体及颅底手术中不断扩大的作用:2014年视角
Surg Neurol Int. 2015 May 20;6:82. doi: 10.4103/2152-7806.157442. eCollection 2015.
8
Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.颅咽管瘤治疗后的内分泌、神经和视觉并发症。
J Neurooncol. 2011 Feb;101(3):463-76. doi: 10.1007/s11060-010-0265-y. Epub 2010 Jun 10.